Samsara Biocapital 13F annual report (2024) | wallmine CA
According to the last 13-F report filed with the SEC, Miran Ahmad serves as the Chief Financial Officer at Samsara Biocapital. Recent trades In the most recent 13F filing, Samsara Biocapital …
OFF
Samsara Biocapital 13F Annual Report (2024) | Wallmine
1 week from now
$646 billion Assets Under Management (AUM) As of 8th May 2024, Samsara Biocapital’s top holding is 6,788,609 shares of Scholar Rock Hldg Corp currently worth over $121 billion and …
wallmine.com
OFF
Samsara Biocapital 13F Annual Report (2024) | Wallmine
1 week from now
Samsara Biocapital 13F annual report Samsara Biocapital is an investment fund managing more than $3.16 billion ran by Miran Ahmad. There is currently 1 company in Mr. Ahmad’s portfolio. …
wallmine.com
OFF
Samsara Biocapital 13F Annual Report (2024) | Wallmine
1 week from now
Samsara Biocapital 13F annual report Samsara Biocapital is an investment fund managing more than $646 billion ran by Miran Ahmad. There are currently 37 companies in Mr. Ahmad’s …
wallmine.com
OFF
SAMSARA BIOCAPITAL, LLC Top 13F Holdings - WhaleWisdom.com
1 week from now
Their last reported 13F filing for Q2 2024 included $477,799,472 in managed 13F securities and a top 10 holdings concentration of 73.56%. Samsara Biocapital's largest holding is CARGO …
whalewisdom.com
OFF
Samsara BioCapital, LLC - 13F
1 week from now
Samsara BioCapital, LLC reported 40 holdings with total value $478 M as of Q2 2024. ... 13F Portfolio Filings Most recent 13F Q2 2024. Location Palo Alto, CA CIK 0001744967 All SEC …
13f.info
OFF
Samsara Biocapital 13F Annual Report (2023) | Wallmine
1 week from now
$3.16 billion Assets Under Management (AUM) As of 8th February 2023, Samsara Biocapital’s top holding is 881,450 shares of Syros Pharmaceuticals currently worth over $3.16 billion and …
wallmine.com
OFF
Samsara BioCapital, LLC Q2 2024 13F Top Portfolio Holdings
1 week from now
Aug 14, 2024 · Samsara BioCapital, LLC reported 40 holdings with total value $478 M as of Q2 2024. Top holdings included CRGX, MLYS, SRRK, NGNE, and ACLX. Samsara BioCapital, …
13f.info
OFF
Samsara Biocapital 13F Annual Report (2024) | Wallmine
1 week from now
As of 8th February 2023, Samsara Biocapital’s top holding is 881,450 shares of Syros Pharmaceuticals currently worth over $3.16 billion and making up 100.0% of the portfolio …
wallmine.com
OFF
SAMSARA BIOCAPITAL, LLC Top 13F Holdings - WhaleWisdom.com
1 week from now
Their last reported 13F filing for Q2 2024 included $477,799,472 in managed 13F securities and a top 10 holdings concentration of 73.56%. Samsara Biocapital's largest holding is CARGO …
whalewisdom.com
OFF
Greenoaks Capital Partners 13F Annual Report (2024) | Wallmine
1 week from now
Greenoaks Capital Partners closed its position in Samsara on 14th November 2023. It sold the previously owned 3,819,902 shares for $46.1 million. Patrick Lai also disclosed a decreased …
wallmine.com
OFF
Jbf Capital 13F Annual Report (2024) | Wallmine CA
1 week from now
Jbf Capital 13F annual report. Jbf Capital is an investment fund managing more than $646 billion ran by John Fullerton. There are currently 81 companies in Mr. Fullerton’s portfolio. The …
wallmine.com
OFF
General Catalyst Management 13F Annual Report - Wallmine
1 week from now
As of 7th August 2024, General Catalyst Management’s top holding is 26,297,056 shares of Samsara currently worth over $886 billion and making up 76.4% of the portfolio value. Relative …
wallmine.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
